Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Excessive DCA significantly decreased the abundance of Eubacterium plexicaudatum, bacterium 1xD42-87 and Ruminococcus flavefaciens, which were positively correlated with the downregulation of multiple metabolites reported to possess anti-inflammatory activities, especially indoles, vitamin D3 and alpha-CEHC.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Wild-type C57BL/6 J mice were orally administrated with or without 0.2% DCA for 12 weeks, then the alteration of gut microbiota signature and fecal metabolites were analyzed by metagenomic sequencing and widely-targeted metabolomics, respectively.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Multi-omics analyses unveil gut microbiota and metabolites signatures in deoxycholic acid-associated intestinal inflammation

Study design awaiting verification · Frontiers in Microbiology · 2026

Original publication title

Multi-omics analyses unveil gut microbiota and metabolites signatures in deoxycholic acid-associated intestinal inflammation

Gaojie Zhang; Ye Huang; Zizhen Gong; Congfeng Xu; Xianglin Ding; Wei Cai; Jin Wu

Copyright © 2026 Zhang, Huang, Gong, Xu, Ding, Cai and Wu.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study revealed that excessive DCA led to concurrent alterations of gut microbiota and metabolites, which exhibited significant correlations with intestinal inflammation, suggesting a potential indirect regulatory pathway that may involve gut microbiota. Targeting DCA-related gut microbiota or metabolites might represent a promising intervention for HFD-associated colonic inflammation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

High-fat diet (HFD) is closely related to the increased incidence of inflammatory bowel disease (IBD), and excessive fecal deoxycholic acid (DCA) induced by HFD makes significant contribution to the colonic inflammation. However, the precise mechanisms remain unclear. This study aims to explore the association between DCA-induced alteration of gut microbiota as well as related metabolites and intestinal inflammation.

Source: Objective

Abstract: What methods does the paper describe?

Wild-type C57BL/6 J mice were orally administrated with or without 0.2% DCA for 12 weeks, then the alteration of gut microbiota signature and fecal metabolites were analyzed by metagenomic sequencing and widely-targeted metabolomics, respectively. The colonic tissue injury was confirmed by histopathological analysis and pro-inflammatory cytokines production was determined by qPCR and ELISA.

Source: Methods

Abstract: Results

DCA administration induced gut microbiota dysbiosis and fecal metabolomic profile disturbance, accompanied with significantly increased expression of pro-inflammatory cytokines in intestine, including TNF-α, IL-6 and IL-1β, and obvious tissue damage. Specifically, α-diversity of gut microbiota was greatly reduced by excessive DCA, and abundance analysis together with linear discriminant analysis of effect size (LEfSe) identified Bacteroides and Desulfovibrio as potential biomarkers of DCA exposure. Excessive DCA significantly decreased the abundance of Eubacterium plexicaudatum, bacterium 1xD42-87 and Ruminococcus flavefaciens, which were positively correlated with the downregulation of multiple metabolites reported to possess anti-inflammatory activities, especially indoles, vitamin D3 and alpha-CEHC.

Meanwhile, DCA administration dramatically increased the abundance of Parabacteroides distasonis and Bacteroide acidifacien, which were positively correlated with the upregulation of metabolites reported to have pro-inflammatory properties, including multiple bile acid metabolites such as chenodeoxycholic acid, glycochenodeoxycholic acid and lithocholic acid. Spearman correlation analysis emphasized the important effects of aforementioned microbiota and metabolites in the association between DCA and intestinal inflammation.

Source: Results

Abstract: Conclusion

Our study revealed that excessive DCA led to concurrent alterations of gut microbiota and metabolites, which exhibited significant correlations with intestinal inflammation, suggesting a potential indirect regulatory pathway that may involve gut microbiota. Targeting DCA-related gut microbiota or metabolites might represent a promising intervention for HFD-associated colonic inflammation.

Source: Conclusion
Authors’ abstract

Objective

High-fat diet (HFD) is closely related to the increased incidence of inflammatory bowel disease (IBD), and excessive fecal deoxycholic acid (DCA) induced by HFD makes significant contribution to the colonic inflammation. However, the precise mechanisms remain unclear. This study aims to explore the association between DCA-induced alteration of gut microbiota as well as related metabolites and intestinal inflammation.

Methods

Wild-type C57BL/6 J mice were orally administrated with or without 0.2% DCA for 12 weeks, then the alteration of gut microbiota signature and fecal metabolites were analyzed by metagenomic sequencing and widely-targeted metabolomics, respectively. The colonic tissue injury was confirmed by histopathological analysis and pro-inflammatory cytokines production was determined by qPCR and ELISA.

Results

DCA administration induced gut microbiota dysbiosis and fecal metabolomic profile disturbance, accompanied with significantly increased expression of pro-inflammatory cytokines in intestine, including TNF-α, IL-6 and IL-1β, and obvious tissue damage. Specifically, α-diversity of gut microbiota was greatly reduced by excessive DCA, and abundance analysis together with linear discriminant analysis of effect size (LEfSe) identified Bacteroides and Desulfovibrio as potential biomarkers of DCA exposure. Excessive DCA significantly decreased the abundance of Eubacterium plexicaudatum, bacterium 1xD42-87 and Ruminococcus flavefaciens, which were positively correlated with the downregulation of multiple metabolites reported to possess anti-inflammatory activities, especially indoles, vitamin D3 and alpha-CEHC.

Meanwhile, DCA administration dramatically increased the abundance of Parabacteroides distasonis and Bacteroide acidifacien, which were positively correlated with the upregulation of metabolites reported to have pro-inflammatory properties, including multiple bile acid metabolites such as chenodeoxycholic acid, glycochenodeoxycholic acid and lithocholic acid. Spearman correlation analysis emphasized the important effects of aforementioned microbiota and metabolites in the association between DCA and intestinal inflammation.

Conclusion

Our study revealed that excessive DCA led to concurrent alterations of gut microbiota and metabolites, which exhibited significant correlations with intestinal inflammation, suggesting a potential indirect regulatory pathway that may involve gut microbiota. Targeting DCA-related gut microbiota or metabolites might represent a promising intervention for HFD-associated colonic inflammation.

Publication and source details

Original title: Multi-omics analyses unveil gut microbiota and metabolites signatures in deoxycholic acid-associated intestinal inflammation

Gaojie Zhang; Ye Huang; Zizhen Gong; Congfeng Xu; Xianglin Ding; Wei Cai; Jin Wu

Frontiers in Microbiology · 2026

* Correspondence: Xianglin Ding, Darnic5911@163.com; Wei Cai, caiw204@sjtu.edu.cn; Jin Wu, wujin@xinhuamed.com.cn
†

These authors have contributed equally to this work

Copyright © 2026 Zhang, Huang, Gong, Xu, Ding, Cai and Wu.2026Zhang, Huang, Gong, Xu, Ding, Cai and Wuhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by grants from Natural Science Foundation of Shanghai (24ZR1459600) and Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (11DZ2260500).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:44:27.004861+00:00

DOI: 10.3389/fmicb.2026.1917982 · PMC13582423